Amendment #2 to Technology License AgreementAn Amending Agreement • March 24th, 2022 • Oragenics Inc • Pharmaceutical preparations
Contract Type FiledMarch 24th, 2022 Company IndustryWHEREAS the Parties entered into a Technology License Agreement signed by NRC on July 26, 2021 with NRC reference number A-0039781 and amendment #1 signed by the NRC on September 2nd, 2021 with NRC reference number A-0041119 (together called the “Original Agreement”).
THIS IS AN AMENDING AGREEMENT made this 4th day of October, 2018. BETWEEN: CEN BIOTECH INC (Buyer) (herein "CEN") and - STEVAN POKRAJAC and TESLA DIGITAL INC and TESLA DIGITAL GLOBAL GROUP INC (Seller) (herein "PTT”)An Amending Agreement • October 9th, 2018 • Cen Biotech Inc • Pharmaceutical preparations
Contract Type FiledOctober 9th, 2018 Company IndustryAND WHEREAS it is desirous that paragraph 2 of the said Amending Agreement be amended in accordance with the terms herein.
CEN BIOTECH INC. (Buyer)An Amending Agreement • April 8th, 2019 • Cen Biotech Inc • Pharmaceutical preparations
Contract Type FiledApril 8th, 2019 Company IndustryAND WHEREAS it is desirous that paragraph 2 of the said Amending Agreement be amended in accordance with the terms herein.
THIS IS AN AMENDING AGREEMENT made this 16th day of March, 2020. BETWEEN:An Amending Agreement • March 17th, 2020 • Cen Biotech Inc • Pharmaceutical preparations
Contract Type FiledMarch 17th, 2020 Company IndustryAND WHEREAS it is desirous that paragraph 2 of the said Amending Agreement be amended in accordance with the terms herein.